Skip to main content
Fig. 6 | Journal of Pharmaceutical Health Care and Sciences

Fig. 6

From: Clinical relevance between sodium-glucose co-transporter 2 inhibitors and lipid profiles in Asian patients with type 2 diabetes mellitus: a systematic review with a meta-analysis of randomized controlled trials

Fig. 6

Relationship between SGLT2is and changes in LDL-C. Abbreviations: CANA, canagliflozin; EMPA, empagliflozin; IPRA, ipragliflozin; LUSEO, luseogliflozin; TOFO, tofogliflozin; SGLT2i, sodium-glucose co-transporter 2 inhibitor; LDL-C, low-density lipoprotein cholesterol; CI, confidence interval; SD, standard deviation.

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us